Clover Health Investments... (CLOV)
NASDAQ: CLOV
· Real-Time Price · USD
3.25
0.25 (8.33%)
At close: Sep 23, 2025, 3:59 PM
3.25
0.00%
After-hours: Sep 23, 2025, 07:59 PM EDT
8.33% (1D)
Bid | 3.2 |
Market Cap | 1.66B |
Revenue (ttm) | 1.61B |
Net Income (ttm) | -43.1M |
EPS (ttm) | -0.08 |
PE Ratio (ttm) | -40.62 |
Forward PE | -60 |
Analyst | Buy |
Dividends | n/a |
Ask | 3.3 |
Volume | 8,875,529 |
Avg. Volume (20D) | 8,874,385 |
Open | 3.01 |
Previous Close | 3.00 |
Day's Range | 2.99 - 3.34 |
52-Week Range | 2.12 - 4.87 |
Beta | 1.97 |
Ex-Dividend Date | n/a |
About CLOV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLOV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLOV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsClover Health Investments Corp. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-20.7%
Clover Health Investments shares are trading lower...
Unlock content with
Pro Subscription
4 months ago
+12.54%
Clover Health Investments shares are trading higher. The company reported Q1 financial results.

1 month ago · seekingalpha.com
Clover Health: Short-Term Pain Hides Its Long-Term Profitability PotentialWhile Clover Health's Q2 earnings showed continued member and revenue growth, it dropped 30% since then due to higher medical costs that impacted all MA plan providers. Clover Health still maintains i...

1 month ago · fool.com
Clover Health (CLOV) Q2 Sales Up 34%Clover Health (CLOV) Q2 Sales Up 34%

1 month ago · seekingalpha.com
Clover Health Investments, Corp. (CLOV) Q2 2025 Earnings Call TranscriptClover Health Investments, Corp. (NASDAQ:CLOV ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Andrew Toy - Co-Founder, CEO & Director Peter J. Kuipers - Chief Financi...